DORIS GARCIA: Open Payments
NPI 1518691708 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 17 payments from 6 companies in 2025. Trend: 2023 $315 · 2024 $179 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $340 |
| ABBVIE INC. | 4 | $162 |
| Ardelyx, Inc. | 1 | $123 |
| Novo Nordisk Inc | 4 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $45 |
Products named: REZDIFFRA, CREON, IBSRELA, Wegovy, XIFAXAN, REBYOTA, LINZESS.
Industry payments across FL — which companies pay providers there.
